New discovery may help reduce side effects of MS drugs

/About-Us/MSF-News-Articles/2022/2345.aspx?lang=en-US 21/03/2022 11:09:45 a. m.

FDA approves Ocrevus Zunovo for relapsing and primary progressive MS

/About-Us/MSF-News-Articles/2024/2481.aspx?lang=en-US 16/09/2024 01:41:51 p. m.

Women less likely than men to receive MS drugs

/About-Us/MSF-News-Articles/2025/2520.aspx?lang=en-US 04/08/2025 10:49:09 a. m.

Study suggests BTK inhibitor slows MS disability progression as effectively as Ocrevus

/About-Us/MSF-News-Articles/2025/2534.aspx?lang=en-US 12/11/2025 10:42:38 a. m.

Fenebrutinib reduces disability progression in primary progressive MS

/About-Us/MSF-News-Articles/2026/2545.aspx?lang=en-US 10/02/2026 12:51:05 p. m.

Study suggests fenebrutinib’s potential as BTK Inhibitor

/About-Us/MSF-News-Articles/2026/2547.aspx?lang=en-US 03/03/2026 10:38:44 a. m.

MS Focus at Sea Notebook - Part 3

/Magazine/Magazine-Items/Posted/MS-Focus-at-Sea-Notebook,-Part-3.aspx?lang=en-US 16/04/2018 12:25:03 p. m.

New study probes link between Epstein Barr, MS treatments

/About-Us/MSF-News-Articles/2024/2454.aspx?lang=en-US 09/04/2024 11:02:19 a. m.

7 Ways to Bloom Where You’re Planted

/Magazine/Magazine-Items/Posted/7-Ways-to-Bloom-Where-You’re-Planted.aspx?lang=en-US 18/04/2017 03:29:09 p. m.